type 1 diabetes

Dexcom’s CEO claims company has a ‘compelling’ case for broader CGM use
MedCity News
Wed, 06/30/21 - 10:10 pm
DexCom
devices
continuous glucose monitoring
diabetes
type 1 diabetes
type 2 diabetes
ViaCyte reports positive cell replacement result for diabetes
Biopharma Reporter
Tue, 06/29/21 - 10:50 am
ViaCyte
islet cell replacement
type 1 diabetes
diabetes
FDA Action Alert: Vericel and Provention Bio
BioSpace
Mon, 06/28/21 - 06:51 pm
Vericel
NexoBrid
Provention Bio
teplizumab
type 1 diabetes
FDA
FDA adcomm votes in favor of approving Provention Bio’s drug to delay type 1 diabetes
Endpoints
Thu, 05/27/21 - 11:57 pm
Provention Bio
FDA
teplizumab
type 1 diabetes
FDA Grants vTv’s Type 1 Diabetes Drug Breakthrough Therapy Designation
BioSpace
Tue, 04/13/21 - 10:01 pm
vTv Therapeutics
TTP399
type 1 diabetes
breakthrough therapies
FDA
Provention warns FDA requests could delay diabetes approval
Fierce Biotech
Fri, 04/9/21 - 10:46 am
Provention Bio
FDA
teplizumab
type 1 diabetes
Provention Bio gives update on teplizumab BLA, FDA feedback
Seeking Alpha
Thu, 04/8/21 - 07:34 pm
Provention Bio
FDA
teplizumab
type 1 diabetes
Vertex begins human testing for diabetes cell therapy
BioPharma Dive
Wed, 03/10/21 - 10:46 pm
Vertex
type 1 diabetes
cell therapy
VX-880
The diabetes 'cure' Vertex acquired in its 2019 Semma buyout? It's headed to the clinic
Endpoints
Fri, 01/29/21 - 09:54 am
Vertex Pharmaceuticals
Semma Therapeutics
M&A
gene therapy
VX-880
type 1 diabetes
Lilly amps Type 1 diabetes partnerships to reach more young people
Fierce Pharma
Thu, 01/28/21 - 10:40 am
Eli Lilly
pharma marketing
type 1 diabetes
Novo Nordisk scraps Type 1 diabetes drug after phase 2 trial
Fierce Biotech
Fri, 10/30/20 - 10:16 am
Novo Nordisk
NN9828
Victoza
clinical trials
type 1 diabetes
FDA urged to increase safety warnings on common diabetes drug
Beckers Hospital Review
Thu, 06/25/20 - 10:48 am
Public Citizen
diabetes
citizen petitions
SGLT2 inhibitor
type 1 diabetes
Preventing Type 1 diabetes by deleting a stress response gene
Fierce Biotech
Fri, 03/27/20 - 10:26 am
type 1 diabetes
diabetes
beta cells
FDA blocks Lilly, Boehringer's Jardiance from coveted Type 1 diabetes nod
Fierce Pharma
Mon, 03/23/20 - 11:54 am
Eli Lilly
Boehringer Ingelheim
Jardiance
type 1 diabetes
diabetes
empagliflozin
First-of-its-Kind Bio-Artificial Pancreas on Track for Type-I Diabetes Cure
CP WIre
Mon, 02/3/20 - 12:45 pm
diabetes
type 1 diabetes
artificial pancreas
Beta-O2 Technologies
devices
FDA OKs Novo's Fiasp for diabetic children
Seeking Alpha
Mon, 01/6/20 - 10:36 am
insulin
FDA
Novo Nordisk
Fiasp
pediatrics
diabetes
type 1 diabetes
Lexicon Pharma shares plummet after FDA denies appeal against drug rejection
Reuters
Tue, 12/3/19 - 12:08 am
Lexicon Pharmaceuticals
FDA
type 1 diabetes
Zynquista
FDA Panel Votes Against Lilly's Jardiance for Type I Diabetes
Zacks.com
Thu, 11/14/19 - 10:25 am
Eli Lilly
Boehringer Ingelheim
FDA
Jardiance
type 1 diabetes
Sanofi shows off positive PhIII trial results for Toujeo, opening the door to a new group of diabetes patients
Endpoints
Mon, 11/4/19 - 10:09 am
Sanofi
clinical trials
type 1 diabetes
insulin
Toujeo
AstraZeneca's Farxiga scores FDA nod to cut risk of hospitalization for heart failure in diabetics
Endpoints
Mon, 10/21/19 - 10:08 am
AstraZeneca
Farxiga
type 1 diabetes
heart failure

Pages